Sep 16, 2019 Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma Learn More
Sep 10, 2019 Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019 Learn More
Sep 4, 2019 Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop Learn More